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Rab3A, Rab3B, Rab3C, and Rab3D constitute a family
of GTP-binding proteins that are implicated in regulated
exocytosis. Various localizations and distinct functions
have been proposed for different and occasionally even
for the same Rab3 protein. This is exemplified by studies
demonstrating that deletion of Rab3A in knock-out mice
results in dysregulation of the final stages of exocytosis,
whereas overexpression of Rab3A in neuroendocrine cells
causes nearly complete inhibition of Ca2-triggered exo-
cytosis. We have now examined the properties of all Rab3
proteins in the same assays, with the long-term goal of
identifying a common conceptual framework for their
functions. Using quantitative immunoblotting, we found
that all four Rab3 proteins were expressed in brain and
endocrine tissues, although at widely different levels.
Rab3A, Rab3B, and Rab3C co-localized to synaptic and
secretory vesicles consistent with potential redundancy,
whereas Rab3D was expressed at high levels only in the
endocrine pituitary (where it was more abundant than
Rab3A, Rab3B, and Rab3C combined), in exocrine glands,
and in adipose tissue. In transfected PC12 cells, all four
Rab3 proteins strongly inhibited Ca2-triggered exocyto-
sis. Except for a mutation that fixes Rab3 into a per-
manently GDP-bound state, all Rab3 mutations tested
had no effect on this inhibition, including a mutation
in the calmodulin-binding site that was described as
inactivating (Coppola, T., Perret-Menoud, V., Lu¨thi, S.,
Farnsworth, C. C., Glomset, J. A., and Regazzi, R. (1999)
EMBO J. 18, 5885–5891). Unexpectedly, overexpression
of wild type Rab3A and permanently GTP-bound mu-
tant Rab3A in PC12 cells caused a loss of secretory
vesicles and an increase in constitutive, Ca2-inde-
pendent exocytosis that correlated with the inhibition
of regulated Ca2-triggered exocytosis. Our data indi-
cate that overexpression of Rab3 in PC12 cells impairs
the normal control of the final step in exocytosis,
thereby converting the regulated secretory pathway
into a constitutive pathway. These results offer an hy-
pothesis that reconciles Rab3 transfection and knock-
out studies by suggesting that Rab3 functions as a gate-
keeper of a late stage in exocytosis.
Rab3 proteins form a family of related GTP-binding proteins
called Rab3A, Rab3B, Rab3C, and Rab3D that function in
regulated exocytosis. Rab3A is an abundant synaptic vesicle
protein (1) and the most abundant Rab protein in the brain (2).
Rab3C has also been localized to synaptic vesicles, and both
Rab3A and Rab3C coordinately dissociate from synaptic vesi-
cles during exocytosis (3, 4). Rab3D is expressed primarily
outside the brain in exocrine glands and in mast cells where it
is enriched on secretory vesicles (5–7), but conflicting data have
been reported about the localization of Rab3B (8–10).
Few proteins have been endowed with as many contradictory
attributes as Rab3. For example, co-expression of multiple
Rab3s was observed in several cell types, but some studies
describe a differential localization of different Rab3s in the
same cell (10–12), whereas other studies find a similar local-
ization (4). In some reports, transfection experiments have
revealed that Rab3 proteins have distinct, isoform-specific
functions (13), but in other studies they were associated with
similar functions (14, 15). Furthermore, even for the same
Rab3 protein, different approaches have suggested distinct,
non-overlapping functions. For example, deletion of Rab3A in
knock-out mice leads to a relatively mild phenotype that in-
cludes altered short-term synaptic plasticity and the absence of
a presynaptic form of long-term potentiation (16, 17). Trans-
fection of Rab3A into PC12 cells and chromaffin cells, by con-
trast, causes a dramatic phenotype resulting in an almost
complete inhibition of exocytosis (14, 18, 19). Moreover, the
knock-out data indicate a role for Rab3A unrelated to vesicle
docking (16), but microscopy studies of PC12 cells overexpress-
ing Rab3A suggest a function in vesicle docking (20).
Based on these data and many others in the literature, it has
been difficult to formulate a coherent hypothesis about the
localization and functions of Rab3 proteins. One potential prob-
lem is that many studies have examined only a subset of Rab3
proteins, making it impossible to compare results from differ-
ent studies. Another potential problem is that all assays of
Rab3 function, be it knock-out mice or transfected cells, have
distinct limitations and are inherently indirect. For example,
the relatively mild phenotype in the Rab3A knock-out could be
a misleading consequence of redundancy among Rab3 isoforms,
whereas the inhibition of exocytosis by transfected Rab3A in
PC12 cells could be because of defective biogenesis of vesicles
and may be unrelated to exocytosis as such. To address these
problems, at least partially, we have now directly compared the
localization of all four Rab3 proteins using specific, standard-
ized antibodies and quantitation of the protein levels. In addi-
tion, we have explored the mechanism by which Rab3 proteins
inhibit exocytosis in transfected PC12 cells. We find that al-
though the four Rab3 proteins are differentially distributed in
vertebrates, all Rab3s appear to be localized on secretory ves-
icles. This observation suggests similar functions for and po-
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tential redundancy among Rab3 proteins, as confirmed by the
finding that all four Rab3s strongly inhibited exocytosis in
transfected PC12 cells. However, when we examined the mech-
anism of this inhibition using a series of mutants of Rab3A, the
best studied Rab3 protein, we found that Rab3A overexpression
did not directly inhibit exocytosis. Instead, Rab3A overexpres-
sion activated Ca2-independent constitutive exocytosis, indi-
cating that Rab3A is essential for a normal regulation of the
final step of exocytosis. These findings agree well with studies
of the Rab3A knock-out mice, which also suggested a selective
role of Rab3A in the terminal stages of exocytosis.
EXPERIMENTAL PROCEDURES
Materials—Enzymes for DNA manipulations were from Roche Mo-
lecular Biochemicals or New England Biolabs (Beverly, MA), fluores-
cence-labeled secondary antibodies from Jackson ImmunoResearch
Laboratories (West Grove, PA), horseradish peroxidase-labeled second-
ary antibodies from BioRad, 125I-labeled secondary anti-rabbit antibody
from Amersham Biosciences, Eupergit C1Z methacrylate microbeads
from Ro¨hm Pharma (Darmstadt, Germany), Ni-NTA-agarose from Qia-
gen (Hilden, Germany), Triton X-114 from Pierce, and nitrocellulose
membranes (Protran) from Schleicher & Schuell (Dassel, Germany). All
other reagents were purchased from Sigma.
Antibodies—Rab3 antisera were raised as described (21) in rabbits
against mouse full-length Rab3B containing a C-terminal hexahistidine
tag (U953 and U954), full-length Rab3D with an N-terminal hexahis-
tidine tag (SA5838 and SA5839), or keyhole limpet hemocyanin-coupled
peptides with the following amino acid sequences: CASATD-
SRYGQKES (583; residues 2–14 of mouse Rab3A); CNGKPALGDTP
(R3D#2, SA5834; residues 201–211 of mouse Rab3D); and ASEP-
PASPRDAAC (R3D#3, SA5837; residues 2–13 of mouse Rab3D). The
monoclonal antibodies to Rab3 (Cl42.1 and Cl42.2 (22)), Rab5 (Cl621.3
(23)), synaptobrevin 2 (Cl69.1 (24)), NR1 (Cl54.1 (25)), and synaptophy-
sin I (Cl7.2 (26)) and the rabbit polyclonal antibodies to endobrevin (27),
Rab3C (R9, P180, and P181 (4,17)), rabphilin (I734 (28)), and synapto-
physin II (p37 (29)) were described previously. Polyclonal antibodies to
Sec61 and LIMP-II were gifts of Dr. E. Hartmann and Dr. S. Ho¨ning,
respectively (both at the University of Go¨ttingen, Germany). Commer-
cial sources were used for the following antibodies: anti-hexahistidine
(mouse anti-peptide RGSHHHH, Qiagen), RIM 1 (Transduction Labo-
ratories, Lexington, KY), and synaptophysin I (580, Synaptic Systems,
Go¨ttingen, Germany).
Immunoblotting—Samples were diluted with sample buffer (3%
SDS, 50 mM Tris/HCl, 10% glycerol, 50 mM dithiothreitol, 0.1% brom-
phenol blue), heated at 50 °C for 10 min, separated by discontinuous
SDS-PAGE (30), transferred onto nitrocellulose membranes (31), and
probed by immunoblotting using horseradish peroxidase-labeled sec-
ondary antibodies and enhanced chemiluminescence detection (ECL;
Amersham Biosciences) or 125I-labeled secondary antibodies and quan-
tification with a Fujix BAS-5000 (Ray Test, Straubenhardt, Germany)
detector (32). Rab3A, Rab3B, Rab3C, and Rab3D were distinguished
from each other based on isoform-specific antibodies (see Fig. 1) and
migration size. For analysis of tissue samples, hydrophobic proteins of
rat tissue homogenates were enriched by phase partitioning in Triton
X-114 (33). Tissues were homogenized in 10 volumes of homogenization
buffer (0.32 M sucrose, 5 mM HEPES-NaOH, pH 7.4, 0.1 mM EDTA, 200
M phenylmethylsulfonyl fluoride) with an ultra-turrax (lung, skeletal
muscle, heart muscle) or a glass-Teflon potter (all other tissues). Equal
protein amounts of total homogenates (lung and skeletal and heart
muscles) or postnuclear supernatants (all other tissues) were extracted
as described (32, 33), and aliquots of the detergent phase corresponding
to 75 g of the starting homogenate were analyzed by immunoblotting.
All blots were standardized by including known amounts of heterolo-
gously expressed His-tagged Rab3 proteins. Peak areas were back-
ground-subtracted and normalized to signals of recombinant Rab3 to
allow comparison between various Rab isoforms and between different
blots, with Rab3A concentrations in the brain cortex as the reference
point (100%). For LIMP-II and endobrevin, the signal of the tissue with
the highest amount was taken as the reference point.
Immunocytochemistry—Anesthetized adult mice were perfused tran-
scardially with PBS followed by 4% paraformaldehyde in PBS. Brains
were cryoprotected and cut into 20-m frontal sections on a cryomic-
rotome (CM1325, Leica, Bensheim, Germany) as described (34). Slices
were stored in antifreeze (25 mM sodium phosphate buffer, pH 7.3, 30%
ethylene glycol, 20% glycerol) at 20 °C. Immunostaining was per-
formed as described (32, 34). Sections were mounted on gelatin-coated
microscopic slides with N-propylgallate (1,5% in 60% glycerol in PBS)
and viewed in an epifluorescence (Axiophot, Zeiss, Go¨ttingen, Germany)
or confocal microscope (MRC-1024, BioRad).
Expression Vectors—For generation of N-terminally hexahistidine-
tagged expression constructs, mouse Rab3A (primers 1236, CGGGAT-
CCGCTTCCGCCACAGACTCTCGC, and 1209, TCAGCAGGCACAAT-
CCTGATGAGG), Rab3B (primers 931, CATATGGCTTCAGTGACTGA-
TGGTAAGACTGG and 932,GAATTCTGCTGCAGCAGAGGTGGGG-
),and Rab 3C (primers 1238, GGATCCGCCTCTGCACAAGATGCCA-
GG, and 1213, TTAGCAGCCACAGTTGGGCTGTGG) were cloned by
PCR from mouse brain cDNA as template. Mouse Rab3D (primers 1239,
CGGGATCCGCATCCGCTAGTGAGCCCCC, and 1212, CTAACAGCT-
GCAGCTGCTCGGCTG) cDNA was amplified from a plasmid (gift of
Dr. H. Lodish, Cambridge, MA). The PCR products were cloned into
pBluescript II containing a translation initiation sequence and the
N-terminal hexahistidine tag (introduced by primers 1234, CTAGAA-
AGCTTTCCACCATGAGAGGATCGCAT CACCATCACCATCACG, and
1235, (GATCCGTGATGGTGATGGTGATGCGATCCTCTCATGGTGG-
AAAGCTTT), and the complete inserts were transferred into the eu-
karyotic expression vector pcDNA3. A series of Rab3 expression vectors
was constructed for cotransfection studies in PC12 cells (Table I). Wild
type constructs lacking the N-terminal histidine tag were amplified
with the primers 2029 (CGGGATCCACCATGGCTTCCGCCACAGAC-
TCTCGCTAT) and 2037 (GGAATTCTC AGCAGGCACAATCCTGATG-
AGG) for Rab3A, 2038 (CGGGATCCACCATGGCTTCAGTGACTGAT
GGTAAGACTGG) and 2039 (GGAATTCCTAGCAAGAGCAGTTCTGC-
TGGAG) for Rab3B, 2040 (CGGGATCCACCA TGAGACACGAGGCG-
CCCATGCAGATGGCCTCTGCACAAGATGCCAGGTTTG) and 2043
(GGAATTCTTAGCA GCCACAGTTGGGCTGTGG) for Rab3C, and
2044 (CGGGATCCACCATGGCATCCGCTAGTGAGCCCCCT) and
2047 (GGAATTCCTAACAGCTGCAGCTGCTCGGCTG) for Rab3D.
Mutations were introduced by PCR with the following primers: 2029,
2031 (GGTGCGGTACCGCTCTAGACCTGCTGTGTCCC), 2030 (GGG-
ACACAGCAGGTCTAGAG CGGTACCGCACC), and 2037 for Rab3A
Q81L; 2029, 2438 (GACCTTGGAGTCTATGCCAACGGTGCTG), 2437
(CAGCACCGTTGGCATAGACTCCAAGGTC), and 2037 for Rab3A
F59S; 2029, 2461 (CCTGGGCATTGTC CGTCGAGTAAGTT), 2460 (AA-
CTTACTCGACGGACAATGCCCAGG), and2037 for Rab3A W125T;
2340 (TGATCATTGGGAACAGCAGCGTGGGCAAAAACTCGTT) and
2037 for a fragment replacing the BclI and EcoRI wild type sequence
and generating Rab3A T36N; 2029 and 2361 (AGATCTGCAGCTT-
GATCGTCTTGTCGTTGAGGTAGATG) for a fragment replacing the
BamHI and BglII wild type sequence and generating Rab3A R66L
R70T; and 2038 and 2339 (CTGCAGCTTCACAGTCTTCTCATGGAG-
GTAGACT) for a fragment replacing the BamHI and PstI wild type
sequence and generating Rab3B R66L R70T. Bacterial expression vec-
tors for antigens for immunization were generated as follows. Rab3B
was amplified with the primers 931 (CATATGGCTTCAGTGACTGAT-
GGTAAGACTGG) and 932 (GAATTCTGCTGCAGCAGAGGTGGGG)
and subcloned into the vector pHO2c (modified pET2, Novagen, Madi-
son, WI), resulting in a C-terminal hexahistidine tag for affinity puri-
fication over Ni-NTA-agarose. Rab3D was amplified with primers with
the sequence CGCATATGGCATCCGCTAGTG and GCGGATCCTAAC-
AGCTGCAGC and subcloned into pET15b (Novagen), resulting in an
N-terminal hexahistidine tag for affinity purification. Bacterial expres-
sion was performed in Escherichia coli strain BL21(DE3). All constructs
were verified by sequencing. Mouse Rab3B and Rab3C sequences were
submitted to GenBankTM (accession numbers AF312036 and
AF312037).
Measurements of hGH1 Secretion from Intact PC12 Cells—PC12 cells
(obtained from the ATCC) were maintained in RPMI 1640 medium
containing 10% heat-inactivated horse serum, 5% fetal bovine serum,
and penicillin and streptomycin (50 u/ml each) at 37 °C in a 5% CO2
humidified atmosphere. PC12 cells were split from a confluent flask and
seeded after vigorous trituration onto 6-well plates (35-mm diameter) to
achieve 50–60% confluence on the day of transfection. Typically, 1 g of
phGH-CMV5 and 1 g of test plasmid DNA/well were co-transfected
using Fugene 6 transfection reagent (Roche Molecular Biochemicals) at
a ratio of 1:3 (g: l) according to the manufacturer’s specifications. 2–3
days after transfection, PC12 cells were collected and replated onto
collagen-coated 12-well plates (22-mm diameter) at a ratio of four
22-mm wells/each transfected 35-mm well. The next day, cells were
briefly rinsed with Krebs bicarbonate buffer (KBB; 118 mM NaCl, 25
1 The abbreviations used are: hGH, human growth hormone; KBB,
Krebs bicarbonate buffer; PBS, phosphate-buffered saline; SNARE, sol-
uble NSF attachment protein receptors.
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mM NaHCO3, 3.5 mM KCl, 1.25 mM CaCl2, 1.2 mM MgSO4, 1.2 mM
KH2PO4, 11.5 mM glucose, 5 mM HEPES-NaOH, pH 7.5), and incubated
for 15 min at 37 °C in 5% CO2 atmosphere with KBB (for basal secre-
tion) or stimulating media (high potassium KBB: 56 mM KCl and 59.5
mM NaCl; or 0.5 nM -latrotoxin in KBB). Assay media were cleared by
centrifugation at 1000  g for 4–5 min, and EDTA was added to 4–5
mM. Corresponding PC12 cells were lysed in PBS containing 1 mM
EDTA and 0.5 mM phenylmethylsulfonyl fluoride by three cycles of
rapid freezing and thawing. Resulting cell extracts were cleared by
high-speed centrifugation. The amounts of hGH secreted into the me-
dium and remaining in the cell extracts were quantified by radioimmu-
noassay (Nichols Institute Diagnostics).
Measurements of Secretion from Permeabilized PC12 Cells—Cells
were transfected as described above. One 6-well plate was used per each
construct. 3–4 days after transfection, cells were collected and divided
into two groups. One part, equivalent to the amount of PC12 cells in one
35-mm well, was re-plated onto four collagen-coated 22-mm wells and
processed for the standard secretion assays from intact PC12 cells. The
remainder of the transfected cells was used in cracked PC12 cell secre-
tion assays modified from Klenchin et al. (35). Cells were washed with
KBB followed by a second washing with ice-cold KGlu buffer (120 mM
potassium glutamate, 20 mM potassium acetate, 2 mM EGTA, 20 mM
HEPES-NaOH, pH 7.2). Cells were resuspended in 6 ml of KGlu buffer
and permeabilized by freezing at 80 °C overnight followed by slow
thawing at room temperature. EGTA was added to 10 mM, and cells
were left on ice for 1–2 h to allow efficient extraction of cytosolic
proteins. Resulting cell ghosts were washed 2–3 times with KGlu buffer
containing 1 mg/ml bovine serum albumin. PC12 cell ghosts prepared
from one 6-well plate were used in 20–32 assay reactions. Each reaction
mixture contained washed PC12 cell ghosts, 2 mM Mg-ATP, 10% rat
brain cytosol (6–10 mg/ml total protein), and varying concentrations of
calcium in the total reaction volume of 200 l of KGlu buffer. Free Ca2
concentrations in the EGTA-Ca2 buffer were calculated using EqCal
software (Biosoft). Reactions were incubated at 30 °C for 20 min, chilled
on ice, and centrifuged at 3,000 g for 10 min. To determine total cellular
hGH levels, pelleted PC12 ghosts were lysed in PBS containing 1 mM
EDTA and 0.5 mM phenylmethylsulfonyl fluoride by three cycles of
rapid freezing and thawing. Resulting ghost extracts were cleared by
high-speed centrifugation. The amounts of hGH secreted into the me-
dium and remaining in the PC12 ghost extracts were quantified by
radioimmunoassay (Nichols Institute Diagnostics).
Subcellular Fractionations—Isolation of small synaptic vesicles was
done as described previously (36). For immunoisolation of organelles,
monoclonal antibodies Cl69.1 (anti-synaptobrevin 2), Cl42.2 (anti-
Rab3A), and Cl621.3 (anti-Rab5) were coupled covalently to Eupergit
C1Z methacrylate microbeads, and isolations from rat brain homoge-
nates were performed as described previously (37, 38). To study the
effects of overexpression of Rab3A on subcellular localization of hGH,
PC12 were co-transfected with the hGH expression vector and either
the empty control vector or the Rab3 expression vector as described
above. Three days after transfections, PC12 cells were labeled overnight
with [3H]norepinephrine (Amersham Biosciences, 6 Ci, 30–50 Ci/
mmol/6-well plate) in the presence of 0.5 mM ascorbic acid. The next
day, cells were washed with KBB, resuspended in 0.25 ml of ice-cold
water, and incubated for 5 min on ice. Cell suspension was diluted with
an equal volume of 2 TNE buffer (1 150 mM NaCl, 2 mM EGTA, 20
mM Tris-HCl, pH 7.5), and passed 10 times through a 28.5-gauge
needle. Cell homogenate was centrifuged twice at 800  g for 10 min to
obtain postnuclear supernatant. 0.4 ml of postnuclear supernatant was
loaded onto 10 ml of discontinuous sucrose gradients made of 2-ml steps
of 0.25, 0.5, 1, 1.5, and 2 M sucrose in TNE buffer and centrifuged at
35,000 rpm for 2.5 h (SW41 rotor200,000 g). Fractions of 0.5–0.6 ml
were collected from the top of the gradients. The amounts of norepi-
nephrine in the fractions were determined directly by liquid scintilla-
tion counting. To measure hGH, fractions were diluted with PBS, sub-
jected to three cycles of rapid freezing and thawing, and analyzed by
radioimmunoassay. For analysis of protein markers, fractions were
diluted 10 times with TNE buffer and centrifuged overnight at
200,000  g. Membranes were resuspended in SDS-PAGE loading
buffer and analyzed by immunoblotting.
Quantitation of Extracellular hGH—PC12 cell transfections were
performed as described for the secretion assays. Aliquots of the extra-
cellular media (50 l) were collected on days 2, 3, and 4 after transfec-
tion, diluted 10 times with PBS containing 5 mM EDTA, and assayed for
hGH. On day 4 after transfection, the PC12 cells were collected, washed
with PBS, and lysed by three cycles of freezing and thawing to deter-
mine the intracellular hGH. The amount of hGH secreted into the
culture media on days 2, 3, and 4 was normalized in comparison with
the amount of hGH remaining in PC12 cells at the day 4.
Miscellaneous—Protein concentrations were determined using the
BCA method (Pierce) according to the manufacturer’s specifications.
RNA blotting experiments were performed with isoform-specific probes
and commercial RNA blots (obtained from Clontech Inc.).
RESULTS
Generation of Isoform-specific Rab3 Antibodies—Although
prior studies have examined the tissue distributions of Rab3
proteins (e.g. see Ref. 39), no study has compared all four Rab3
proteins, and no measurements of the relative levels of differ-
ent Rab3s have been attempted. One of the four Rab3 proteins,
Rab3B, has not even been studied yet at the protein level,
presumably because of a lack of specific antibodies. Therefore
our first goal was to generate specific antibodies to all four
Rab3 proteins, and to measure their sensitivity and specificity.
We chose to study Rab3 proteins with antibodies instead of
simply measuring the Rab3 mRNAs because it is difficult to
quantify mRNA levels for comparisons between different pro-
teins and because mRNA levels often do not correlate with
protein levels; this proved to be particularly true for Rab3
proteins (see below).
We characterized a total of nine antibodies to the four Rab3
proteins, using either newly generated (583, U953, U954,
R3D#2, R3D#3, SA5838, and SA5839) or previously charac-
terized antibodies (Cl42.1 and 42.2; P180 and P181; Refs. 17
and 22). The antibodies were examined with recombinant
Rab3A, 3B, 3C, and 3D proteins that were produced as fusion
proteins with an N-terminal histidine tag in transfected 293
cells. The Rab3 proteins were synthesized in the transfected
cells at different levels. To obtain cells with the same overall
protein concentrations and the same amounts of the respective
recombinant Rab3 proteins, we adjusted extracts from trans-
fected 293 cells with extracts from untransfected 293 cells until
equivalent signals were obtained with an antibody to the hexa-
histidine tag attached to all recombinant Rab3 proteins. Cell
extracts containing nearly identical amounts of Rab3A, Rab3B,
Rab3C, or Rab3D were then analyzed by immunoblotting with
the various antibodies.
Fig. 1 shows that most of the antibodies we tested were
either completely specific or nearly specific for the Rab3 protein
against which they are raised, providing us with the tools
required for examining the level and localization of the respec-
tive Rab3 proteins in tissues. Only two antibodies reacted with
all four Rab3 proteins: the previously described monoclonal
antibody Cl42.1 (22, 40), which, however, only weakly recog-
nized Rab3D, and the newly generated antibody SA5839
(against full-length mouse Rab3D), which reacted preferen-
tially with Rab3D (Fig. 1). Rab3 proteins display distinct mi-
gration patterns that can be used as an identifying mark in
addition to the specificity of the antibodies. Although Rab3C,
due to the presence of eight additional N-terminal amino acids,
has the highest calculated molecular weight, Rab3D exhibited
the slowest electrophoretic mobility, followed by Rab3C, 3A,
and 3B (Fig. 1). It should be noted that in transiently trans-
fected 293 cells, the post-translational geranylgeranylation of
Rab3 proteins is incomplete, presumably because the overex-
pressed proteins overwhelm the geranylgeranylation capacity
of the cells (41). As a result, an immature lower band and a
mature upper band are observed for Rab3 proteins in trans-
fected 293 cells but not in rat tissue samples (Fig. 1, data not
shown).
Tissue Distribution of Rab3 Proteins—To quantify the levels
of Rab3A, Rab3B, Rab3C, and Rab3D in different organs, we
first extracted fractions from 18 rat tissues with Triton X-114
to enrich for hydrophobic proteins (33). This was done to in-
crease the sensitivity of detection of Rab3 proteins. Rab3 pro-
teins are hydrophobic, because of their C-terminal geranylgera-
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nyl modification, and are co-purified with membrane proteins
by Triton X-114 extraction (41, 42). We then measured the
amount of each Rab3 protein relative to a standard amount of
heterologously expressed Rab3 analyzed on the same blot; im-
munoblotting signals were quantified using 125I-labeled sec-
ondary antibodies and detected by phosphorimaging. As posi-
tive controls, the broadly distributed lysosomal protein
LIMP-II and the endosomal protein endobrevin were examined
on the same blots. Because the antibody signals were normal-
ized via the common histidine tag present on all recombinant
Rab3 standards, it was possible to express the total amount of
each Rab3 protein in relation to Rab3A, using the amount of
Rab3A in brain cortex as the reference point (Fig. 2).
As expected, protein quantification showed that Rab3A was
the most abundant Rab3 isoform in brain and was largely
co-distributed with Rab3C in the brain and the pituitary gland
(4). Rab3B, however, was also detected in all brain areas and
was most abundant in the pituitary (Fig. 2). These findings
were confirmed by immunoblotting analyses of different brain
areas, which revealed that Rab3A is uniformly present
throughout the brain, whereas Rab3B was expressed at high
levels only in the olfactory bulb and the pituitary, and Rab3C
was synthesized at variable levels in all brain areas (Fig. 3A).
The overall distribution of Rab3D was strikingly different from
that of Rab3A, Rab3B, and Rab3C, which are largely co-ex-
pressed in neuronal and endocrine tissue (Fig. 2). Rab3D was
also detected in the brain, albeit at very low levels, but was
observed at unexpectedly high concentrations in the pituitary,
where it constituted the most abundant Rab3 protein (Figs. 2
and 3B and data not shown). Dissection of the pituitary into
adeno- and neurohypophysis revealed that Rab3 proteins are
differentially distributed, with Rab3A and 3C expressed pri-
marily in the neurohypophysis and Rab3B and Rab3D in the
adenohypophysis (Fig. 3B). As described previously (5–7), the
highest amounts of Rab3D were measured in the lachrymal,
parotid, and submandibular glands and the pancreas. The ab-
solute levels of Rab3D in lachrymal and parotid glands were
twice as high as those of Rab3A in brain (Fig. 2). Rab3D was
also broadly distributed outside of the pituitary and exocrine
glands, for example in lymph nodes and adipose tissues as
described previously (43). In many tissues, however, we did not
detect significant amounts of any Rab3 protein, most notably in
the lung, liver, kidney, testis, and spleen. The control mem-
brane proteins LIMP-II and endobrevin were quite abundant in
all of these tissues that together make up the bulk of the body
mass outside of the brain. The absence of Rab3A protein in the
testis was surprising in view of extensive previous data de-
scribing Rab3A as an important mediator of acrosomal fusion
in sperm (15, 44, 45) but agrees well with the fact that Rab3A
knock-out males are fertile (2).
In addition to the immunoblotting analyses, we performed
RNA blotting experiments to test whether Rab3 mRNA and
protein levels correlate. As expected, the highest mRNA signals
for Rab3A, Rab3B, and Rab3C were observed in the brain (data
not shown). Unexpectedly, however, we found significant levels
of Rab3A mRNA in the lung and testis even though no protein
was detectable in these tissues. Similarly, we observed rela-
tively high mRNA levels for Rab3D in the lung in the absence
of Rab3D protein (data not shown). These results show that the
mRNA levels of a Rab3 protein are not necessarily indicative of
protein expression in a tissue, although it is unclear whether
there is translational regulation that depresses production of
Rab3 proteins in these tissues or whether the synthesized Rab3
proteins are unstable and degraded in these tissues.
Co-localization of Rab3A, 3B, and 3C on Synaptic Vesi-
cles—To determine whether all three Rab3 proteins that are
abundant in the brain, Rab3A, Rab3B, and Rab3C, are present
on synaptic vesicles, we performed subcellular fractionations
(Fig. 4 and data not shown) and immunocytochemistry (Fig. 5).
We purified synaptic vesicles by differential centrifugation fol-
lowed by controlled pore-glass chromatography, currently the
most rigorous purification method of synaptic vesicles (36). Fig.
4 shows that Rab3B co-purified with Rab3A and synaptophy-
sin, a well established synaptic vesicle protein (26), suggesting
that Rab3B is also a synaptic vesicle protein. To test this
conclusion by an independent approach, we performed or-
ganelle immunoprecipitation from the brain with antibodies to
synaptobrevin 2 (a SNARE protein of synaptic vesicles),
Rab3A, and Rab5 (a Rab protein that is equally present on
synaptic vesicles and several other intracellular membranes
FIG. 1. Standardization of antibodies to Rab3A, Rab3B, Rab3C, and Rab3D. Murine Rab3A, Rab3B, Rab3C, and Rab3D were expressed
in 293 cells by transient transfection as fusion proteins with an N-terminal six-histidine (hexahistidine) tag. Five days after transfection,
postnuclear supernatants were prepared and analyzed by SDS-PAGE and immunoblotting (20 g protein/lane) using the indicated two monoclonal
antibodies (Cl42.2 and Cl42.1) and nine polyclonal antibodies (583, U953, U954, P180, P181, R3D#2, R3D#3, SA5838, and SA5839). In addition,
samples were blotted with an antibody against the hexahistidine tag (His6) because the hexahistidine tag is present on all Rab3s and can thus
be used to standardize the amounts of Rab3 proteins loaded. Samples were adjusted so that each contained the same amount of Rab3 protein as
measured with the His6 antibody by diluting the extracts from transfected cells with extracts of untransfected cells. Signals were visualized using
horseradish peroxidase-coupled secondary antibodies and ECL, as shown here, or 125I-labeled secondary antibodies and phosphorimaging detection
for quantitation (not shown). An asterisk indicates cross-reactivity of the antibodies with a human protein in 293 cells.
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(23)). Immunoprecipitated organelles (see “Experimental Pro-
cedures” and Ref. 37) were highly enriched in synaptophysin as
a synaptic vesicle marker and contained abundant amounts of
Rab3A, Rab3B, and Rab3C (data not shown). This result con-
firms that Rab3A, Rab3B, and Rab3C are all present on syn-
aptic vesicles, suggesting a greater range of potential redun-
dancy among Rab3 proteins than previously anticipated. To
examine how much the localization of Rab3B overlaps with
that of Rab3A, we studied the distribution of Rab3A and 3B in
olfactory bulb by immunocytochemistry (Fig. 5). Olfactory bulb
was chosen for these experiments because it contains relatively
high levels of Rab3B (see lane 1, Fig. 3B). Immunofluorescence
double labeling of cryostat sections revealed that Rab3A was
widely distributed in the olfactory bulb, whereas Rab3B was
present in a more restricted pattern. All Rab3B-positive struc-
tures were also labeled by Rab3A antibodies, although many
Rab3A-positive structures did not contain Rab3B (see right
panels in Fig. 5). Because Rab3A was previously shown to be
synaptic (1, 22), this result indicates that Rab3B is present in
synapses and that all synapses containing Rab3B also contain
Rab3A, although Rab3A appears to be present in a large num-
ber of synapses without Rab3B.
Rab3 Proteins Inhibit Ca2-triggered Exocytosis in PC12
Cells Independently of Interactions with Potential Target Mol-
ecules—The co-distribution of Rab3A, Rab3B, and Rab3C on
synaptic vesicles in the brain, the corresponding localization of
Rab3D on secretory vesicles in exocrine glands, and the overall
sequence homology between these proteins suggest similar
functions in regulated secretion. Consistent with this hypoth-
esis and with previous results (14, 15), transfection of all four
Rab3s severely inhibited Ca2-triggered exocytosis (Fig. 6).
This was measured by testing the effect of a co-transfected
Rab3 protein on the exocytosis of transfected human growth
hormone (hGH) in PC12 cells stimulated by K-depolarization
or with -latrotoxin. As a negative control, an empty expression
vector was co-transfected with hGH. The Rab3-dependent in-
hibition of Ca2-triggered exocytosis was not caused by impair-
ment of voltage-gated Ca2-channels because the inhibition
FIG. 2. Quantitation of the relative expression of Rab3A, Rab3B, Rab3C, and Rab3D in rat tissues. Homogenates of the indicated rat
tissues were extracted with Triton X-114 to enrich for Rab3 proteins that carry a C-terminal geranylgeranyl modification, which renders them
hydrophobic. Equivalent amounts of proteins (corresponding to 75 g of starting material) were analyzed by SDS-PAGE and immunoblotting with
antibodies to Rab3A (Cl42.2), Rab3B (U954), Rab3C (P180), and Rab3D (aR3D#2) (see Fig. 1). Signals were quantified using 125I-labeled secondary
antibodies on a Fujix BAS-5000. Equal amounts of heterologously expressed Rab3 proteins were analyzed on each blot, and signal intensities were
standardized. All values are normalized for the amount of Rab3A in the brain cortex (100%). As a positive control, all samples were examined with
antibodies to the ubiquitous intracellular proteins LIMP-II and endobrevin (bottom two panels). The data for the control proteins were normalized
to the levels in tissues that contain the highest amounts of LIMP-II and endobrevin (pituitary and kidney, correspondingly).
FIG. 3. Distribution of Rab3A,
Rab3B, Rab3C, and Rab3D in brain
and pituitary. A, proteins in the post-
nuclear supernatant from the mouse
brain regions shown were analyzed by im-
munoblotting with antibodies to the indi-
cated proteins (NR 1, NMDA-receptor
subunit 1). Note the relative enrichment
of Rab3B in the pituitary. B, immunoblot
analysis of proteins in postnuclear super-
natants from rat olfactory bulb (OB), neu-
rohypophysis (NH), and adenohypophysis
(AH) with antibodies to the indicated pro-
teins. In A and B, 30 g of protein/lane
were analyzed, and signals were visual-
ized by ECL.
Localization and Function of Rab3 Isoforms 40923
 at M














was equally observed with K depolarization (which opens
Ca2-channels) and -latrotoxin (which acts in PC12 cells by a
Ca2-dependent mechanism that does not involve Ca2-chan-
nels; see Ref. 46).
The magnitude of the effect of inhibition of exocytosis by
Rab3 is puzzling in view of the mildness of the Rab3A knock-
out phenotype (2, 16). To elucidate the mechanism of this
inhibition, we first tested whether membrane attachment of
Rab3A is essential for inhibition by comparing wild type Rab3A
with a mutant lacking the C terminus, which is modified by
geranylgeranylation (41). The C-terminally truncated Rab3A
was as effective as the wild type in inhibiting Ca2-triggered
exocytosis (Fig. 7A). This result was confirmed with Rab3A
proteins that were N-terminally fused to GFP, which allowed
us to visualize the transfected cells and to evaluate the loca-
tions of the transfected proteins (data not shown). In these
experiments, the transfected cells appeared to express similar
levels of Rab3 proteins that exhibited distinct localizations
depending on their GTP-binding status. The transfected cells
looked normal, without evidence of cellular pathology, indicat-
ing that the transfected proteins were not cytotoxic.
We next measured the effect of wild type and C-terminally
truncated Rab3A on Ca2-triggered secretion from PC12 cells
that had been cracked open by freeze-thawing after transfec-
tion of hGH and control or test plasmids. If PC12 cells are
permeabilized by freeze-thawing 3 days after transfection, se-
cretory granules containing transfected hGH remain associ-
ated with the plasma membrane in the resulting PC12 cell
ghosts and can be stimulated for exocytosis by the addition of
Ca2 (35, 47). In the cracked PC12 cell ghosts, inhibition by
wild type Rab3A was not as effective as in the whole cell assay,
whereas the C-terminally truncated version was more effective
(Fig. 7B). One possible explanation for these results is that the
transfected Rab3 proteins change the Ca2-dependence of exo-
cytosis. The more moderate inhibition by wild type Rab3A in
the cracked cells could then be explained by the fact that Ca2
is supplied at higher concentrations to the sites of exocytosis in
the cracked cells. To address this possibility, we tested the
relative inhibition of exocytosis by wild type Rab3A and by the
GTP-fixed Rab3A mutant at different Ca2-concentrations
(Fig. 8). In control cells, a bell-shaped Ca2-dependence of
exocytosis was observed with a maximum at 3 M free Ca2,
similar to previous results (47). In cells transfected with wild
type Rab3A or the permanently GTP-bound mutant of Rab3A,
exocytosis was inhibited at all Ca2-concentrations (Fig. 8).
This result demonstrates that Rab3A does not simply shift the
Ca2-dependence of exocytosis, and thus it acts at a step dis-
tinct from the Ca2-triggering step.
What Sequences of Rab3 Are Required for Inhibition of Exo-
cytosis?—We tested a series of mutants of Rab3A and Rab3B
that disrupt known activities of Rab3 proteins, in order to
clarify a number of contradictory results in the literature, most
importantly the finding that the calmodulin-binding site in
Rab3A is essential for its inhibitory activity in transfected
PC12 cells (48) despite the fact that calmodulin is not required
for Ca2-triggered exocytosis in PC12 cells as such (49). Similar
to previous findings (Ref. 14; but note Ref. 48), we observed
that wild type and constitutively GTP-bound Rab3A (Q81L)
were equally active in inhibiting exocytosis (Fig. 9). This find-
ing was similarly obtained for all four Rab3 isoforms (Table I).
In contrast, the constitutively GDP-bound form of Rab3A
(T36N) was inactive. Furthermore, we examined a Rab3A mu-
tant that is deficient in GTP-dependent binding of rabphilin
(F59S (14)) and another point mutant of Rab3A in which a
tryptophan residue that is characteristic for Rab3 proteins but
absent from most other Rab proteins is replaced by a threonine
(W125T). Neither of these mutations interfered with the ability
of Rab3A to inhibit exocytosis (Fig. 9). Finally, we tested the
mutation in the calmodulin binding site or Rab3A (R66L/
R70T), which inactivated the inhibitory effect of Rab3A in
previous studies (48). However, in the present experiments this
mutation did not change the inhibitory effect of Rab3A (Fig. 9).
To ensure that this discrepancy was not due to an incalculable
peculiarity of our Rab3A clone, we inserted the same mutation
into the Rab3B expression vector where it again had no effect
on inhibition (Fig. 9; Table I). This result indicates that none of
the currently known effectors of Rab3A is responsible for its
inhibitory effect on Ca2-triggered exocytosis in PC12 cells.
Rab3A Activates Constitutive Exocytosis—The observation
that Rab3A inhibits Ca2-triggered exocytosis more effectively
FIG. 4. Localization of Rab3A and 3B to synaptic vesicles. Im-
munoblot analysis of fractions obtained during the purification of syn-
aptic vesicles by differential centrifugation and controlled pore-glass
chromatography. Equivalent amounts of proteins were analyzed by
immunoblotting using antibodies to the lysosomal membrane protein
LIMP-II as a negative control and to the synaptic vesicle protein syn-
aptophysin 1 as a positive control in addition to antibodies to Rab3A
and Rab3B. H, homogenate; P1, crude nuclear pellet; S2, 10,000  g
supernatant; P2, crude synaptosomes (10,000 g pellet); LP1, 25,000
g pellet obtained after synaptosomal lysis; LP2, crude synaptic vesicles
(100,000 g pellet); PI and PIII, large membrane and purified synaptic
vesicle fractions, respectively, as separated by controlled-pore glass
bead chromatography (for details, see Refs. 36 and 52).
FIG. 5. Immunofluoresence localization of Rab3A and Rab3B
in the olfactory bulb. A cryosection of mouse olfactory bulb (20-m
thickness) was double-labeled with antibodies to Rab3A (red signals)
and Rab3B (green signals). Panels on the left show low-power overviews
obtained with an epifluorescence microscope (bar  30 m), and panels
on the right show high-power views produced with a confocal micro-
scope (the central panel on right depicts the merged signal, with the
overlap between red and green shown as yellow; bar  20 m). epl,
external plexiform layer; gl, glomerulus; gr, granule cell layer; ipl, inner
plexiform layer; mc, mitral cell layer.
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in intact transfected PC12 cells than in cracked transfected
PC12 cells (Fig. 7) suggests that the transfected protein may
impair the biogenesis or disposition of secretory granules. To
address this possibility, we expressed either hGH alone or hGH
and Rab3A in transfected PC12 cells and then labeled dense
core vesicles in the cells with [3H]norepinephrine. The cells
were then lysed and subfractionated on a sucrose gradient.
Each fraction was analyzed by scintillation counting for [3H]-
norepinephrine, by radioimmunoassay for hGH, and by immu-
noblotting for synaptic proteins (Fig. 10). The results revealed
that Rab3A, synaptotagmin 1, and SNARE proteins co-mi-
grated in two major peaks on the gradient, the second of which
coincided with the peak of [3H]norepinephrine and hGH. Syn-
aptophysin, on the other hand, was much more abundant on
the first peak. These characteristics suggest that the first peak
corresponds to synaptic-like microvesicles, which are enriched
in synaptophysin, whereas the second peak corresponds to
large dense core vesicles (50, 51). In Rab3A-transfected cells,
the size of the second peak containing hGH is decreased but not
shifted, whereas the norepinephrine peak (which serves as an
internal control for vesicles derived from nontransfected cells
in the same population) is unchanged. This observation indi-
cates that Rab3A transfection may inhibit production of hGH,
slow down the biogenesis of dense core vesicles, or promote the
nonregulated exocytosis leading to a secondary loss of the
vesicles.
To differentiate between these three possibilities, we first
measured the total content of hGH produced in transfected
cells as a function of co-transfection with wild type or mutant
Rab3A. Transfection of wild type or GTP-fixed Rab3A de-
creased the hGH content 4-fold (Fig. 11). Some reduction,
however, is expected from co-transfection of another protein
with hGH alone because any co-expression of another protein
with hGH dilutes the transcription and translation factors and
thus decreases the amount of hGH produced. Indeed, in trans-
fected PC12 cells expressing GDP-fixed Rab3A (which does not
inhibit Ca2-triggered exocytosis; see Fig. 9), the hGH levels
are decreased 2-fold compared with controls (Fig. 11). Viewed
in this light, the decrease in the hGH levels in the Rab3A
transfected PC12 cells is not as great, suggesting that approx-
imately half of the hGH is lost compared with the GDP form.
However, loss of hGH in the large, dense core vesicle fraction
(Fig. 10) appears to be more severe than the overall decrease of
hGH in the cells (Fig. 11), indicating that it is not the biosyn-
thesis of hGH but either its packaging into vesicles or the
regulation of secretion that is impaired.
FIG. 6. Transfected Rab3A, Rab3B,
Rab3C, and Rab3D similarly inhibit
PC12 cell exocytosis stimulated by
KCl depolarization or by -latro-
toxin. An expression vector encoding
hGH was co-transfected into PC12 cells
with an empty expression vector (control),
or Rab3A, Rab3B, Rab3C, or Rab3D ex-
pression vectors. Transfected PC12 cells
were then stimulated for secretion with
56 mM KCl or 0.5 nM -latrotoxin (Ltx) for
15 min, and the hGH released into the
medium was measured by radioimmuno-
assay. The data shown correspond to a
single representative experiment per-
formed in duplicate and repeated multi-
ple times, with inhibition varying be-
tween experiments.
FIG. 7. Comparison of the effect of
transfected Rab3A on Ca2-stimu-
lated exocytosis in intact PC12 cells
(A) or cracked PC12 cells (B). PC12
cells were co-transfected with the hGH
vector and a control vector or expression
vectors for full-length Rab3A or truncated
Rab3A that lacks the C-terminal cys-
teines, which are geranylgeranylated
(Rab3AC). Half of the transfected cells
were analyzed intact using a 15-min KCl
stimulation of secretion. The other half
was “cracked” by freezing and thawing.
Exocytosis of hGH-containing docked
granules was stimulated by Ca2 for 20
min in the presence of rat brain cytosol
and Mg2-ATP. Data are from a single
representative experiment performed in
duplicate and are normalized to the con-
trol condition. Generally, cracked PC12
cells exhibit Ca2-independent and -de-
pendent hGH release rates, respectively,
of 10–15 and 45–50% total hGH/20 min.
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To test why Rab3A overexpression reduced the hGH content
of the transfected cells, we measured the amount of hGH that
is constitutively secreted from co-transfected cells. Fig. 12
shows that co-transfection of wild type Rab3A or mutant
Rab3A that is permanently GTP-bound dramatically increased
the amount of hGH that was secreted into the medium. In
contrast, the GDP-fixed form of Rab3A had no effect compared
with controls (Fig. 12). Because the same Rab3 proteins that
increased constitutive secretion of hGH decreased the total
cellular content of hGH (Fig. 11), the transfected Rab3 proteins
must act by increasing the spontaneous, Ca2-independent
secretion of hGH. An enhancement of constitutive exocytosis
was also observed after transfection of Rab3B, Rab3C, and
Rab3D, suggesting that the general inhibition of exocytosis by
overexpressed wild type Rab3 proteins correlates with a gen-
eral activation of constitutive exocytosis (data not shown).
DISCUSSION
Rab3A, Rab3B, Rab3C, and Rab3D together form a family of
closely related GTP-binding proteins that interact with the
same putative effectors but have been associated with diver-
gent localizations and functions. One persistent problem is that
these proteins have rarely been compared directly in the same
experiment. In addition, most studies did not examine endog-
enous proteins but probed the localizations or effects of trans-
fected proteins. Of the many questions arising from previous
work on Rab3 proteins, the present work was designed to
address two related, potentially important issues. First, do
different Rab3 proteins have distinct or similar localizations
and functions? Second, are the discrepancies between the pro-
posed functions of Rab3 proteins, especially Rab3A, due to
differences in the approaches? For example, the relatively
weak phenotype of the Rab3A knock-out mice could reflect
redundancy among Rab3 proteins, whereas the strong effects of
Rab3A in transfected cells could be an indirect consequence of
a secondary process. We have addressed these questions using
antibodies standardized with recombinant proteins, to examine
the relative expression and localization of the four Rab3 pro-
teins, and transfected PC12 cells, to probe the functions of
FIG. 8. Effect of wild type and GTP-
fixed Rab3A on Ca2-concentration
dependence of hGH secretion from
cracked PC12 cells. PC12 cells co-trans-
fected with a control vector or with vec-
tors expressing wild type and GTP-fixed
Rab3A were cracked as described in the
legend to Fig. 7. Secretion of hGH was
stimulated by the addition of Ca2 at the
indicated concentrations. Data shown are
means  S.E. from a single representa-
tive experiment performed in duplicate
and repeated three times with similar
results.
FIG. 9. Effect of wild type and mu-
tant Rab3 proteins on regulated exo-
cytosis in PC12 cells. PC12 cells were
co-transfected with the hGH expression
vector and either a control vector without
an insert or various Rab3 expression vec-
tors. Exocytosis was then stimulated from
intact cells with 56 mM KCl as described
in the legend to Fig. 6. Expression vectors
encoded wild type Rab3A (3A WT); Rab3A
mutants Q81L and T36N, which fix it in
the GTP- and GDP-bound forms (3A GTP
and 3A GDP, respectively); Rab3A point
mutants F59S and W125T, which inter-
fere with interactions with the putative
effectors RIM and rabphilin; and Rab3A
and Rab3B double mutant R66L/R70T,
referred to as “3B CaM” because it abol-
ishes binding of Rab3s to calmodulin.
Data shown are means  S.E. of normal-
ized results from three independent ex-
periments performed in duplicate.
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Rab3 proteins. Our results suggest the following conclusions.
1. Rab3A, Rab3B, and Rab3C are expressed primarily in the
brain and endocrine cells, whereas Rab3D is synthesized in a
different pattern with the highest levels in exocrine cells and
adipose tissue. These results extend previous data (6, 7, 12, 43)
by quantifying the concentrations of various Rab3 proteins. As
a result, we show for example that the concentration of Rab3D
in the lachrymal and parotid glands is twice that of Rab3A in
the brain (where Rab3A is the most abundant Rab protein (2))
and that most tissues do not express detectable levels of any
Rab3 protein (Fig. 2). The latter point is particularly important
because the presence of significant mRNA levels for some Rab3
forms in the lung, liver, kidney, and testis suggested that these
Rab3 proteins may play an important general role, despite the
fact that no such role was detected in Rab3A knock-out mice.
Clearly the mRNA levels provide only a first approximation to
the place where a protein is actually expressed.
2. In the brain, Rab3A, Rab3B, and Rab3C are co-localized on
synaptic vesicles but exhibit a differential distribution among
brain regions (Figs. 3–5). Rab3A is uniformly present in all
brain areas, Rab3B only in a subset of brain areas with the
TABLE I
Rab3 proteins expressed in PC12 cells by co-transfection with hGH to study the mechanism of Rab3-dependent inhibition of exocytosis
Rab3 Protein Presumptive effect of mutationsa Effect on regulated exocytosisb Effect on constitutive exocytosisc
Rab3A Wild type Strong inhibition Activation
Rab3AC Deletes C-terminal cysteines; thus not
geranylgeranylated
Strong inhibition ND
Rab3A-T36N Inhibits GDP dissociation; thus preferentially
GDP-bound
No inhibition No effect
Rab3A-Q81L Inhibits GTP hydrolysis; thus preferentially
GTP-bound
Strong inhibition Activation
Rab3A-F59S Inhibits GTP-dependent rabphilin binding Strong inhibition ND
Rab3A-W125T Highly conserved Rab3-specific residue Strong inhibition ND
Rab3A-R66L/R70T Inhibits calmodulin binding Strong inhibition ND
Rab3B Wild type Strong inhibition ND
Rab3B-Q81L Inhibits GTP hydrolysis; thus preferentially
GTP-bound
Strong inhibition ND
Rab3B-R66L/R70T Inhibits calmodulin binding Strong inhibition ND
Rab3C Wild type Strong inhibition ND
Rab3C-Q89L Inhibits GTP hydrolysis; thus preferentially
GTP-bound
Strong inhibition ND
Rab3D Wild type Strong inhibition ND
Rab3D-Q81L Inhibits GTP hydrolysis; thus preferentially
GTP-bound
Strong inhibition ND
a Based on Refs. 14 and 48.
b Effect on KCl-, -latrotoxin-, and Ca2-triggered release of co-transfected hGH as shown in Figs. 6–9.
c See Figs. 10–12. ND, not determined.
FIG. 10. Subcellular localization of hGH in mock and Rab3A-
transfected PC12 cells. PC12 cells were co-transfected with hGH and
control vector or Rab3A expression vector. Three days after transfec-
tion, cells were labeled overnight with [3H]norepinephrine and lysed,
and organelles in the postnuclear supernatants were separated on
discontinuous sucrose gradients. Gradient fractions were analyzed by
scintillation counting to measure [3H]norepinephrine, by radioimmuno-
assay to measure hGH, and by immunoblotting for synaptophysin 1
(Syp 1), Rab3A, synaptobrevin 2 (Syb 2), SNAP-25, syntaxin 1, and
synaptotagmin 1 (Syt 1) as indicated. Note that the [3H]norepinephrine
distribution reflects all PC12 cells, whereas the hGH distribution re-
flects only the small percentage of cells (5%) that are transfected.
FIG. 11. Effect of transfection of wild type and mutant Rab3A
proteins on total cellular hGH levels. PC12 cells were co-trans-
fected with the hGH expression vector and with either control or test
expression vectors as described in Fig. 8, and the total cellular levels of
hGH were determined in resting cells. hGH levels are normalized to
control values. Data shown are means  S.E. from five independent
experiments.
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highest levels in olfactory bulb, and Rab3C in most brain areas
but at variable levels. This pattern is very similar to that
observed for other synaptic vesicle proteins, for example syn-
aptophysins, which are expressed in an ubiquitously (synapto-
physin 1) and a variably distributed isoform (synaptophysin
2/synaptoporin; Ref. 29). Rab3D is also present in the brain, but
its levels were too low to allow localization.
3. In transfected PC12 cells, all Rab3 proteins are dominant
inhibitors as long as they bind GTP, but all effector interactions
tested with specific mutants are dispensable for inhibition
(Figs. 6–9; see also Ref. 14). Furthermore, the strong inhibition
observed in intact cells is reduced in cracked cells, indicating
that the inhibition does not operate by blocking a terminal step
in Ca2-triggered exocytosis (Fig. 7). This conclusion is sup-
ported by the fact that the inhibition cannot be “rescued” by
increases in Ca2-concentrations in the permeabilized cells
(Fig. 8). A major limitation of these observations is that they
were obtained in transfected PC12 cells; this does not prove
that endogenous Rab3 proteins are similarly active, an issue
that needs to be resolved using knock-out mice.
4. Finally, overexpression of wild type Rab3A or a Rab3A
mutant that is permanently GTP-bound activates constitutive
secretion of co-transfected hGH, leading to a decrease in the
amount of remaining cellular hGH (Figs. 10–12). This result
demonstrates that Rab3A may not actually inhibit secretion
directly but rather may deplete the transfected cells of dense
core vesicle content by allowing continuous exocytosis of their
cargo. In this regard, Rab3 proteins are similar to Rab11b,
which we recently found to be the only Rab protein tested
among multiple such proteins that inhibited exocytosis.2
Overall, the available data reported in this and other studies
(12, 14, 20) indicate that Rab3A, Rab3B, Rab3C, and Rab3D
are functionally comparable based on similar localizations, a
high degree of sequence homology, and equivalent inhibition of
exocytosis in transfected PC12 cells. Clearly there are major
differences in the cells and tissues that express the different
Rab3 isoforms and possibly also in the functions of Rab3 pro-
teins, because the biogenesis and fusion of secretory vesicles in
exocrine glands containing Rab3D exhibit quite different prop-
erties from the biogenesis and fusion of endocrine and neuronal
secretory vesicles. On the other hand, the high levels of “exo-
crine” Rab3D in the endocrine adenohypophysis (Fig. 3B) sup-
port the notion that Rab3 proteins function similarly in exo-
crine and endocrine exocytosis.
The most important finding of our study may have been the
observation that Rab3A overexpression in PC12 cells activates
constitutive exocytosis, causing an apparent inhibition of Ca2-
triggered exocytosis by depleting the pool of available hGH.
This observation potentially explains contradictory results in
the literature. It suggests that overexpressed GTP- but not
GDP-bound Rab3A can circumvent the Ca2-control of exocy-
tosis. The observation that Ca2 acts in the final stage of
exocytosis, which was also identified in the Rab3A knock-out as
the point where the function of Rab3A becomes apparent, rec-
onciles the knock-out data and the PC12 cell transfection data.
This observation also suggests the reason that a decrease in the
number of total and docked vesicles was observed in trans-
fected PC12 cells expressing Rab3A and 3D (20). Although
viewed together, the results reported here and previously ar-
gue for a general role of Rab3 proteins in the final stage of
exocytosis, the mechanism involved is still unclear. Neverthe-
less, with the emerging convergence of the PC12 cell and
knock-out data, it may now be possible to address this mecha-
nism in further transfection experiments.
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